Ingersoll-Rand Inc
Q1 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +6.60%.
Did IR Beat Earnings? Q1 2026 Results
Ingersoll Rand opened 2026 with a quarter that cleared Wall Street's bar on both top and bottom lines, posting adjusted diluted EPS of $0.77 against a consensus of $0.74, a beat of 4.03%, while revenue of $1.85 billion edged past estimates by 0.92% and grew 7.6% year over year. The headline growth was powered largely by acquisitions and favorable foreign currency, though organic revenue slipped 0.3%, a dynamic that also weighed on the Industrial Technologies and Services segment, where adjusted EBITDA margin compressed 210 basis points to 26.7%. The brighter spot was Precision and Science Technologies, which delivered 4% organic revenue growth and margin expansion of 120 basis points to 30.3%. Despite the solid beat, the stock has come under pressure, trading near a 52-week low as investors weigh tariff-related headwinds against management's steady full-year outlook, which calls for revenue growth of 2.5% to 4.5% and adjusted EPS of $3.45 to $3.57, representing approximately 5% growth at the midpoint.
- Ingersoll Rand Execution Excellence (IRX) methodology driving operational discipline
- Acquisitions contributed 3.7% to reported revenue growth
- Foreign currency contributed 4.2% to reported revenue growth
- P&ST segment organic revenue growth of 4% with 120 bps margin expansion
- Tariff pricing offset tariff costs one-for-one in IT&S
- IT&S book-to-bill ratio of 1.08x
“We began 2026 with solid momentum, delivering high single-digit Adjusted EPS growth and meeting our expectations for Revenue and Adjusted EBITDA. With a robust M&A pipeline, we remain confident in reaching our annual revenue target. Our Economic Growth Engine, IRX, and ownership mindset will continue to support disciplined execution and durable value creation.”
Ingersoll Rand CEO, on the earnings call
Forward Guidance & Outlook
Ingersoll Rand is maintaining its full-year 2026 guidance: revenue growth of 2.5% to 4.5% (organic growth flat to 2%, ~2% from M&A, ~0.5% currency), Adjusted EBITDA of $2,130M to $2,190M, Adjusted EPS of $3.45 to $3.57 (+5% growth at midpoint), and free cash flow to adjusted net income conversion of ~95%. Revenue phasing is expected at 48% first half / 52% second half. The company does not expect significant impact from Section 232 tariff changes or the Middle East conflict on full-year guidance. Key assumptions include ~$170M corporate costs, ~$230M net interest expense, ~23% adjusted tax rate, ~394M share count, and CAPEX at ~2% of sales.
IR YoY Financials
IR Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.